A unique social innovation model was implemented during COVID 19 Pandemic in New Zealand, with eight Māori who live with Schizophrenia and health and social challenges.
The social innovation was made possible through a partnership between Te Rau Ora, Waikato District Health Board, Janssen, Johnson & Johnson Global and Manawanui.
The innovation piloted a suite of support led by Māori lived experience workforce, an individualised flexible funding model to support the eight participants to become self-determined in the management of their health and wellbeing. The participants and their whānau received training, support, and guidance from lived experience workforces. The pilot concluded in September 2021, and garnered positive results along with an ongoing commitment between the partners to the social innovation. Mauri Ora II will work with a larger group of Māori, and for a longer term.
For more information visit www.terauora.com